Wellington Management Group LLP Buys 149,951 Shares of Astera Labs, Inc. $ALAB

Wellington Management Group LLP increased its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 151.5% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 248,914 shares of the company’s stock after acquiring an additional 149,951 shares during the period. Wellington Management Group LLP’s holdings in Astera Labs were worth $120,230,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of ALAB. BlackRock Inc. bought a new stake in shares of Astera Labs during the 2nd quarter worth approximately $6,609,581,000. Atreides Management LP raised its position in Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after acquiring an additional 1,754,593 shares in the last quarter. State Street Corp raised its position in Astera Labs by 32.5% during the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after acquiring an additional 760,358 shares in the last quarter. Geode Capital Management LLC lifted its stake in Astera Labs by 4.5% in the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after acquiring an additional 104,935 shares during the last quarter. Finally, Bank of America Corp DE bought a new position in shares of Astera Labs in the 2nd quarter valued at about $1,061,791,000. 60.47% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total value of $2,804,599.02. Following the completion of the transaction, the director directly owned 3,970 shares of the company’s stock, valued at $1,237,965.10. The trade was a 69.38% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of the company’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the sale, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. The trade was a 7.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 406,745 shares of company stock valued at $158,581,158 in the last quarter. Company insiders own 10.40% of the company’s stock.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $279.91 on Wednesday. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The firm has a market cap of $48.56 billion, a price-to-earnings ratio of 138.57 and a beta of 3.78. The firm’s 50-day simple moving average is $337.19 and its 200 day simple moving average is $251.85.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same quarter in the previous year, the firm posted $0.44 EPS. The business’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Sell-side analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current year.

Analyst Ratings Changes

Several brokerages recently issued reports on ALAB. Susquehanna raised their target price on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research note on Friday, July 31st. UBS Group reaffirmed a “neutral” rating and issued a $425.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. Evercore reissued an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a report on Tuesday, May 19th. JPMorgan Chase & Co. raised their price target on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Finally, Zacks Research raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $348.33.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.